Richard A. Franco is Director at SALIX PHARMACEUTICALS LTD (SLXP). They have made 13 open-market trades across 2 companies since 2006, most recently 2012-12-21.
CIK 0001212673
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $236K since 2006, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLXP | SELL · 10b5-1 | 2012-03-16 | 2012-03-20 | $51.98 | $487K | N/A | N/A | N/A |
| DARA | BUY | 2011-04-26 | 2011-04-26 | $2.78 | $10K | N/A | N/A | N/A |
| SLXP | SELL | 2010-11-22 | 2010-11-24 | $43.80 | $110K | N/A | N/A | N/A |
| SLXP | SELL | 2010-09-03 | 2010-09-08 | $40.00 | $260K | N/A | N/A | N/A |
| DARA | BUY | 2010-09-02 | 2010-09-03 | $2.64 | $13K | N/A | N/A | N/A |
| DARA | BUY | 2010-08-31 | 2010-08-31 | $2.29 | $11K | N/A | N/A | N/A |
| SLXP | SELL | 2010-08-26 | 2010-08-30 | $39.01 | $254K | N/A | N/A | N/A |
| DARA | BUY | 2010-05-24 | 2010-05-24 | $4.18 | $8K | N/A | N/A | N/A |
| DARA | BUY | 2010-05-20 | 2010-05-20 | $4.45 | $4K | N/A | N/A | N/A |
| DARA | BUY | 2010-05-19 | 2010-05-19 | $3.85 | $12K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2010-05-03 | 2010-05-05 | $40.22 | $201K | N/A | N/A | N/A |
| SLXP | SELL | 2009-08-14 | 2009-08-18 | $12.57 | $65K | N/A | N/A | N/A |
| SLXP | SELL | 2008-12-22 | 2008-12-22 | $8.51 | $30K | N/A | N/A | N/A |
| SLXP | BUY | 2008-05-13 | 2008-05-14 | $6.83 | $85K | N/A | N/A | N/A |
| DARA | BUY | 2008-02-22 | 2008-02-25 | $1.90 | $19K | N/A | N/A | N/A |
| SLXP | SELL | 2007-11-12 | 2007-11-13 | $11.32 | $58K | N/A | N/A | N/A |
| SLXP | BUY | 2006-11-20 | 2006-11-22 | $14.21 | $72K | N/A | N/A | N/A |
| SLXP | SELL | 2006-11-15 | 2006-11-17 | $13.69 | $164K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.